This observational study examines cases of central nervous system (CNS) toxicity associated with methylene blue (MB), particularly its potential to precipitate serotonin toxicity (ST) when combined with serotonergic agents. MB acts as a monoamine oxidase A inhibitor, which, when taken alongside serotonin reuptake inhibitors (SRIs), can lead to dangerously high
